{
  "id": 17811179,
  "title": "Earnings call transcript: Immunovia posts Q3 2026 sales beat as stock rises",
  "url": "https://urgent.news/2026/11/02/earnings-call-transcript-immunovia-posts-q3-2026-sales-beat-as-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-02T15:02:14.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-immunovia-posts-q3-2026-sales-beat-as-stock-rises-93CH-4992171"
  },
  "original_language": "en",
  "account": "Immunovia reported strong third-quarter 2026 results, with net sales of SEK 843,000, a 735% increase year-over-year, surpassing expectations of SEK 500,000. Operating loss narrowed to SEK 17.7 million, down 29.5% from SEK 25.1 million, while monthly cash burn fell to SEK 5 million, below the previously anticipated range of SEK 8 million to SEK 10 million. The company's PancreaSure test is now used in 36 high-risk surveillance programs, with 12 centers achieving full adoption. Immunovia raised approximately SEK 63 million through a rights issue to fund growth and operations. The company's market capitalization stands at just $3.45 million, but the earnings beat and improved cash burn rate indicate growing commercial traction. Immunovia's CEO noted the company's focus on pancreatic cancer diagnostics and highlighted progress in clinical adoption and reimbursement discussions.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Financial Times",
        "title": "Alstom shares tumble 26% after train maker cuts profit forecast",
        "url": "https://urgent.news/2026/11/02/alstom-shares-tumble-26-after-train-maker-cuts-profit-forecast",
        "published": "2026-11-02T08:16:32.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}